awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26795445-0937E678-C079-4EDA-A140-E23E77C55443
Q26795445-0937E678-C079-4EDA-A140-E23E77C55443
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795445-0937E678-C079-4EDA-A140-E23E77C55443
Targeting molecular resistance in castration-resistant prostate cancer
P2860
Q26795445-0937E678-C079-4EDA-A140-E23E77C55443
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795445-0937E678-C079-4EDA-A140-E23E77C55443
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
44c6735a6a25a114a8e64149191f3dc71ca5bbb3
P2860
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial